The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 24, 2012

Filed:

Dec. 16, 2009
Applicants:

Vincent Danial Fitzpatrick, Dayton, NJ (US);

Mark Sliwkowski, San Carlos, CA (US);

Richard L. Vandlen, Hillsborough, CA (US);

Inventors:

Vincent Danial Fitzpatrick, Dayton, NJ (US);

Mark Sliwkowski, San Carlos, CA (US);

Richard L. Vandlen, Hillsborough, CA (US);

Assignee:

Genentech, Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); A61K 39/00 (2006.01); A61K 39/385 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Chimeric heteromultimer adhesins that bind the ligand of natural heromultimeric receptors and uses therefor are disclosed. The chimeric molecules of the heteromultimer adhesins comprise an extracellular domain of a heteromultimeric receptor monomer and a multimerization domain for the stable interaction of the chimeric molecules in the adhesin. Specifically disclosed are heteromultimeric adhesins comprising the extracellular domains of the ErbB2 and ErbB3 and ErbB2 and ErbB4. The chimeric ErB heteromultimer adhesins of the present invention are useful as competitive antagonists or agonists of a neuregulin for the treatment of diseases such as various cancers.


Find Patent Forward Citations

Loading…